LAVA Therapeutics NV Sustainability Reports
LAVA Therapeutics N.V. is a clinical-stage biopharmaceutical company that develops bispecific gamma-delta T-cell engagers to treat cancer.
Sector: Manufacturing
Country: Netherlands
Exchange: Nasdaq
FIGI: BBG00L04L554
1 reports from 2021 to 2021